PTC Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. USO
8. IBM
9. HOOD
10. ABBV

Go back to PTC Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides a Corporate Update

PTC Therapeutics (PTCT) Misses Q4 EPS by 63c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus

February 28, 2019 4:49 PM EST

PTC Therapeutics (NASDAQ: PTCT) reported Q4 EPS of ($0.96), $0.63 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $86.34 million versus the consensus estimate of $84.61 million.

"We are proud to be in the strong position of having a growing revenue... More